Sapporo Clinical Laboratory Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9776?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	235,000	7.53%
Individual Insiders	415,000	13.3%
Institutions	438,600	14.1%
General Public	846,138	27.1%
Private Companies	1,185,000	38%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 14 shareholders own 72.88% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
38%	Date Asset Management G.K.	1,185,000	JP¥1.2b	0%	no data
5.42%	H.U. Group Holdings, Inc.	169,000	JP¥164.1m	0%	no data
4.96%	FMR LLC	154,600	JP¥150.1m	0%	no data
4.04%	Chuichi Date	126,000	JP¥122.3m	0%	no data
3.78%	Shoji Nagai	118,000	JP¥114.6m	4.42%	no data
3.62%	North Pacific Bank, Ltd., Asset Management Arm	113,000	JP¥109.7m	0%	0.1%
3.62%	Hokuhoku Financial Group, Inc., Asset Management Arm	113,000	JP¥109.7m	0%	0.1%
3.3%	Naoki Manda	103,000	JP¥100.0m	0%	no data
2.12%	Hikari Tsushin, Inc.	66,000	JP¥64.1m	0%	no data
1.99%	Tadamasa Date	62,000	JP¥60.2m	0%	no data
1.86%	Sumitomo Life Insurance Co., Asset Management Arm	58,000	JP¥56.3m	0%	no data
0.064%	Yoshiaki Kanagi	2,000	JP¥1.9m	0%	no data
0.064%	Hideo Nagano	2,000	JP¥1.9m	0%	no data
0.064%	Yuko Date	2,000	JP¥1.9m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/23 08:11
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sapporo Clinical Laboratory Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Masao Yoshida	Ichiyoshi Research Institute Inc.